Word

ALGENSCRIBE

Status

Registered

Status Code

700

Status Date

Tuesday, June 25, 2024

Serial Number

79374320

Registration Number

7424131

Registration Date

Tuesday, June 25, 2024

Mark Type

4

Filing Date

Friday, April 7, 2023

Published for Opposition

Tuesday, April 9, 2024

Trademark Owner History

ALGENSCRIBE - Original Registrant

Classifications

5 Veterinary and pharmaceutical preparations, namely, gene-based and cell-based therapeutic preparations for treating cancer; Pharmaceutical preparations for gene and cell therapy; Biological preparations for use in gene therapy and cell therapy for medical purposes; Micro-organism cultures and preparations for medical, pharmaceutical and/or veterinary use; Bacteriological preparations for medical, pharmaceutical and/or veterinary use; Diagnostic reagents and preparations for clinical, medical, pharmaceutical and/or veterinary use; Diagnostic test preparations consisting principally of reagents and assays for clinical, medical, pharmaceutical and/or veterinary use

1 Chemical, biochemical, biotechnological products intended for use in industry, science, agriculture, horticulture, namely, chemical and biochemical preparations for scientific purposes, chemicals for use in biotechnological product development, chemicals and biochemicals used in industry; Chemical, biochemical, biotechnological and bacteriological products for use in research and testing laboratories, namely, chemical and biochemical preparations for research purposes, chemicals for use in biotechnological product development, other than for medical or veterinary purposes; Chemical and biochemical preparations used in the manufacture of pharmaceuticals; Biotechnological products used in the manufacture of pharmaceuticals, namely, chemicals for use in biotechnological product development; Chemical preparations used for the production of gene and cell therapies; Diagnostic preparations other than for medical use; Diagnostic reagents and preparations for scientific use; Diagnostic reagents and preparations for scientific laboratories; Reagents for analytical use, namely, chemical analysis reagents other than for medical or veterinary purposes; Reagents for the extraction, preservation and processing of human, animal, plant or microbiological samples for collecting genetic or genomic information other than for medical or veterinary purposes; Diagnostic testing preparations, namely, reagents and assays for scientific use

44 Medical diagnostic services, including diagnostic and reagent sample testing services for third parties; Genetic testing for medical purposes, including genome mapping, genome analysis and genome scanning; Biological, genetic and genomic handling and analysis services for medical use; Medical genetic or genomic testing for detecting risks, diagnosing illness or selecting treatment in humans, animals or plants

42 Scientific and industrial research, namely, chemical research, research and development of new biological and medical products; Scientific genetic, medical, pharmaceutical and veterinary research; Scientific genetic, medical, pharmaceutical and veterinary research, namely, research in the field of pharmaceutical preparations for gene and cell therapy; Research in chemistry, biology, biochemistry, molecular biology; Scientific research in the field of biology, genetics and genomics; Scientific research services using genomic analysis procedures; Biological, scientific genetic and genomic handling and analysis services for scientific use; Structural and functional genome analysis, for scientific purposes; Biotechnological research and development for third parties, including scientific feasibility studies on genetic associations, genome mapping, genome analysis and genome scanning; Scientific analysis in the field of genetics and genomics; Scientific research and development of biochemical analysis, biological analysis and molecular biology techniques; Research and development of new molecules intended for use in industry, preparing and providing biological materials and particularly stem cells; Developing pharmaceutical drugs and therapeutics; Scientific laboratory services, namely, biological material modifications

Trademark Events

Jul 13, 2023

Sn Assigned For Sect 66a Appl From Ib

Jul 21, 2023

Application Filing Receipt Mailed

Jan 4, 2024

Assigned To Examiner

Jul 17, 2023

New Application Office Supplied Data Entered

Jan 11, 2024

Non-Final Action Written

Jan 12, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Jan 29, 2024

Refusal Processed By Mpu

Jan 29, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Feb 13, 2024

Teas/Email Correspondence Entered

Feb 13, 2024

Correspondence Received In Law Office

Feb 13, 2024

Teas Response To Office Action Received

Feb 19, 2024

Refusal Processed By Ib

Mar 6, 2024

Approved For Pub - Principal Register

Mar 20, 2024

Notification Of Notice Of Publication E-Mailed

Mar 27, 2024

Notification Of Possible Opposition Sent To Ib

Mar 27, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 9, 2024

Published For Opposition

Apr 9, 2024

Official Gazette Publication Confirmation E-Mailed

Apr 16, 2024

Notification Processed By Ib

Jun 25, 2024

Registered-Principal Register

Jun 25, 2024

Notice Of Registration Confirmation Emailed